Home
GHRS

GHRS

GH Research PLC

as of 12-12-2025 3:58pm EST

$13.05

$0.75

-5.43%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

#14 in Best Under $20 Stocks

Chart Type:

Time Range:

Founded:	2018	Country:	Ireland
Employees:	N/A	City:	N/A
Market Cap:	892.0M	IPO Year:	2021
Target Price:	$30.11	AVG Volume (30 days):	247.9K
Analyst Decision:	Strong Buy	Number of Analysts:	9
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-0.73	EPS Growth:	N/A
52 Week Low/High:	$6.72 - $20.50	Next Earning Date:	11-06-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered GHRS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold

Model Accuracy: 66.67%

66.67%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full GHRS Forecast & Prediction with Hourly Data

Compare GHRS vs Leading Stocks

See how GHRS stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free GHRS Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "GHRS GH Research PLC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.